IPH Ltd
ASX:IPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IPH Ltd
ASX:IPH
|
AU |
|
NK Rosneft' PAO
MOEX:ROSN
|
RU |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
US |
|
Financial Institutions Inc
NASDAQ:FISI
|
US |
|
ePlus inc
NASDAQ:PLUS
|
US |
|
B
|
Bitfarms Ltd
NASDAQ:BITF
|
CA |
|
C
|
Cleveland-Cliffs Inc
XMUN:CVA
|
US |
|
AKB Avangard PAO
MOEX:AVAN
|
RU |
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
|
C
|
ChipMOS Technologies Inc
F:CPIA
|
TW |
|
B
|
Brixmor Property Group Inc
F:BXR
|
US |
|
St Dupont SA
PAR:DPT
|
FR |
|
Z
|
Zeda Ltd
JSE:ZZD
|
ZA |
|
Peach Property Group AG
F:P6Z
|
CH |
|
Viper Energy Partners LP
NASDAQ:VNOM
|
US |
Wall St Price Targets
IPH Price Targets Summary
IPH Ltd
According to Wall Street analysts, the average 1-year price target for IPH is 4.83 AUD with a low forecast of 3.78 AUD and a high forecast of 6.3 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IPH's stock price target?
Price Target
4.83
AUD
According to Wall Street analysts, the average 1-year price target for IPH is 4.83 AUD with a low forecast of 3.78 AUD and a high forecast of 6.3 AUD.
What is the Revenue forecast for IPH Ltd?
Projected CAGR
2%
Over the last 11 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 5 years is 2%.
What is the Operating Income forecast for IPH Ltd?
Projected CAGR
9%
Over the last 11 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 9%.
What is the Net Income forecast for IPH Ltd?
Projected CAGR
14%
Over the last 11 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 5 years is 14%.
